Table 4.
Summary of phenotypic characterisation of third‐generation cephalosporin resistance in non‐typhoidal Salmonella spp. from food‐producing animals, animal carcases and humans, reported in 2019–2020
| Matrix |
Presumptive ESBL and/or AmpC‐ producers( a ) n (%R) |
Presumptive ESBL‐producers( b ) n (%R) |
Presumptive AmpC‐producers( c ) n (%R) |
Presumptive ESBL + AmpC‐producers( d ) n (%R) |
|---|---|---|---|---|
| Humans – 2019 (N = 14,389, 21 MSs) | 128 (0.9) | 111 (0.8) | 17 (0.1) | 5 (0.03) |
| Humans – 2020 (N = 5,948, 15 MSs) | 45 (0.8) | 35 (0.6) | 10 (0.2) | 1 (0.02) |
| Broiler carcases (N = 905, 18 MSs) | 3 (0.3) | 2 (0.2) | 1 (0.1) | 0 (0) |
| Pig carcases (N = 1,088, 26 MSs) | 5 (0.5) | 3 (0.3) | 2 (0.2) | 0 (0) |
| Broilers (N = 1,955, 22 MSs) | 42 (2.1) | 37 (1.9) | 4 (0.2) | 1 (< 0.1) |
| Laying hens (N = 1,184, 24 MSs) | 2 (0.2) | 1 (0.1) | 1 (0.1) | 0 (0) |
| Fattening turkeys (N = 674, 16 MSs) | 3 (0.4) | 3 (0.4) | 0 | 0 |
| Fattening pigs (N = 359, 8 MSs) | 3 (0.8) | 1 (0.3) | 2 (0.6) | 0 (0) |
N: Total number of isolates reported by the MSs; n: number of the isolates resistant; %R: percentage of resistant isolates; ESBL: extended‐spectrum β‐lactamase.
Isolates exhibiting only ESBL‐ and/or only AmpC‐ and/or combined ESBL+AmpC phenotype.
Isolates exhibiting an ESBL‐ and/or combined ESBL+AmpC‐phenotype.
Isolates exhibiting an AmpC and/or combined ESBL+AmpC‐phenotype.
Isolates exhibiting a combined ESBL+AmpC phenotype.